Skip to content
Elite Drive

The Zimbabwean Government Declines ‘Unbalanced’ American Healthcare Assistance Deal Because of Information Fears

Health funding illustration
The proposed US financial assistance was aimed at initiatives for HIV/Aids treatment and prevention, TB, and malaria.

The nation of Zimbabwe has declined a major American healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years due to the United States' request for sensitive biological samples.

This rejection became public following a government memo dated December was disclosed, revealing that President Emmerson Mnangagwa believed the agreement was "unbalanced".

An official spokesperson has since clarified that the US was demanding access to health data for research and commercial gain while refused to share the benefits from any future vaccines.

"We will now turn to the challenging and unfortunate process of scaling back our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the United States had furnished over $1.9bn for health programmes to Zimbabwe over the last two decades.

A medical body in Zimbabwe has appealed for continued talks to find a deal suitable to all parties so the country's vital HIV treatment initiative can proceed.

Wider Implications

This rejection follows a similar case in neighbouring Kenya, where a high court blocked a related deal with the US following legal challenges were raised about the security of citizens' health data.

After returning to the presidency last year, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.

The agency had overseen aid for the American government, but Trump stated its expenditure was "inefficient" and his government was seeking government-to-government agreements to enhance transparency and responsibility.

According to statements, Sixteen African countries have so far signed similar health pacts, representing more than $18.3bn of fresh investment.

Details of the Declined Deal

The funds for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this partnership would have delivered extraordinary advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently on antiretroviral therapy through US-supported initiatives," Tremont commented.

However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".

"The proposal required Zimbabwe to provide its biological resources and data over an extended period, without any equivalent guarantee of benefiting from any medical innovations – such as new medicines or tests – that might result from that provided information," his statement read.

"Put simply, our nation would provide the raw materials for scientific discovery with no assurance that the resulting innovations would be accessible to our people should a future pandemic arise."

Sovereignty and International Frameworks

Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting systems previously established via the global organization.

Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to manage potential global health emergencies.

"This framework is intended to guarantee that when a country contributes its data, the benefits – including medicines and cures – are shared equitably, not commercialised solely by those with the capability to develop them."

These objections regarding the US deal "should not be misconstrued as opposition to America," he added.

"We are open to continued dialogue with our American counterparts on how subsequent collaboration might be structured in a way that honours the independence and interests of each country."

Health Experts Response

A leading public health body said it understood the government's concerns, but suggested that negotiations should continue considering a large portion of the country's Aids initiatives depended on international support.

"If specific concerns exist, such as those involving information security or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," the group added.

This impasse highlights the continuing debate between receiving much-needed international aid and safeguarding a country's data in an ever more interconnected world.

About the author

Julie Robinson

A seasoned automotive journalist with over 15 years of experience covering luxury cars and industry innovations.

Elite Drive

Type to search articles.